The University of Kansas Cancer Center has joined with trial tech provider Complion to develop a shared investigator platform for use in a range of studies.
Share this article
Share this article
CLEVELAND, May 20, 2021 /PRNewswire/ Complion has developed a best-in-breed Shared Investigator Platform (SIP) integration in partnership with The University of Kansas Cancer Center (KU Cancer Center), which will be readily available across all Complion sites, including the largest base of more than 14,000 clinical trials.
This integration will provide a single standard method for KU Cancer Center to work across the numerous major sponsors it works with on clinical research studies. The integration is the final step necessary to enable KU Cancer Center to fully adopt SIP and achieve the benefits of faster feasibility as well as securing additional studies by eliminating objections from specific sponsors while becoming favorable for other sponsors seeking sites for their studies.
03.17.21 Incorporating The Voices Of Parents And Children In Pediatric Clinical Trials
YPrime eCOA Platform Isn’t it about time for a globally proven eCOA technology that gives you peace of mind? One that provides a better user experience for patients, sites, and sponsors? YPrime’s eCOA platform delivers even the most complex protocol seamlessly. Developed to integrate intelligently with your other technologies, all modalities are available for site- or home-based trials and paired with secure web backup for guaranteed accuracy and confident, informed decision-making.
It’s Time for the Prime eCOA Solution: It’s Time for YPrime.
Featured Editorial
03 10 21 -- Data-Driven Insights To Improve Your Recruitment Process For Clinical Trials clinicalleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalleader.com Daily Mail and Mail on Sunday newspapers.